Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H
Third Department of Internal Medicine, Nara Medical University, Kashihara, Japan.
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S.
Endotoxin plays an important role in the initiation and aggravation of alcoholic liver disease. In this study, we evaluated plasma endotoxin levels and serum concentrations of cytokines and lipopolysaccharide binding protein (LBP) during the acute and recovery phase of patients with alcoholic hepatitis; we also explored the prognostic factors associated with a fatal outcome.
Fourteen patients, consisting of eight patients with alcoholic hepatitis (AH), five cirrhotics with superimposed AH (LC+AH), and one patient with severe alcoholic hepatitis (SAH), were studied. Among these, two with LC+AH died of hepatic failure.
Plasma endotoxin levels in the acute phase were higher in patients with AH (184.4 +/- 159.4 pg/ml) and LC+AH (206.9 +/- 174.9 pg/ml) than in healthy subjects (10.4 +/- 5.5 pg/ml, p < 0.001). In particular, in one patient with SAH and one of two nonsurvivors, plasma endotoxin levels were markedly high relative to the other cases. In most survivors, plasma endotoxin levels decreased in the recovery phase, whereas they further increased at the terminal stage in one of two nonsurvivors. Serum interleukin (IL)-6 and IL-8 levels in the acute phase were significantly higher in patients with AH and LC+AH as compared with healthy subjects. These levels were especially high in nonsurvivors and in one patient with SAH. IL-10 increased in two nonsurvivors, one patient with SAH, and one with LC+AH. In the recovery phase, these cytokine levels in survivors tended to decrease, but in nonsurvivors, IL-6 remained high, and IL-8 and IL-10 further increased. Tumor necrosis factor-alpha levels were below the detection limit throughout the course in all patients. Serum lipopolysaccharide binding protein (LBP) generally was elevated in the acute phase and decreased in the recovery phase in all survivors, but in one of the nonsurvivors, LBP was elevated markedly at the terminal stage. In the acute phase, plasma endotoxin levels were correlated positively with white blood cell counts, neutrophil counts, and serum IL-8. IL-8 was correlated positively with neutrophil counts and negatively with serum cholinesterase, hepaplastin test, and serum albumin levels. IL-6 was correlated positively with white blood cell and neutrophil counts, C-reactive protein, and serum total bilirubin and negatively with hepaplastin test and serum total protein levels. Serum LBP was correlated positively with white blood cell and neutrophil counts.
Endotoxemia and related elevation of IL-8 may play an important role in the activation and migration of neutrophils in patients with alcoholic hepatitis. Marked elevation of inflammatory cytokines, IL-6 and IL-8, are related to severity and poor prognosis of alcoholic hepatitis. Serum LBP may serve as an index of inflammatory reaction in alcoholics.
内毒素在酒精性肝病的发生和加重过程中起重要作用。在本研究中,我们评估了酒精性肝炎患者急性期和恢复期血浆内毒素水平、细胞因子及脂多糖结合蛋白(LBP)的血清浓度;我们还探讨了与致命结局相关的预后因素。
研究了14例患者,其中包括8例酒精性肝炎(AH)患者、5例合并AH的肝硬化患者(LC+AH)和1例重症酒精性肝炎(SAH)患者。其中,2例LC+AH患者死于肝衰竭。
AH患者(184.4±159.4 pg/ml)和LC+AH患者(206.9±174.9 pg/ml)急性期的血浆内毒素水平高于健康受试者(10.4±5.5 pg/ml,p<0.001)。特别是,1例SAH患者和2例非存活者中的1例,其血浆内毒素水平相对于其他病例明显升高。在大多数存活者中,恢复期血浆内毒素水平下降,而2例非存活者中的1例在终末期进一步升高。AH患者和LC+AH患者急性期的血清白细胞介素(IL)-6和IL-8水平显著高于健康受试者。这些水平在非存活者和1例SAH患者中尤其高。IL-10在2例非存活者、1例SAH患者和1例LC+AH患者中升高。在恢复期,存活者的这些细胞因子水平趋于下降,但在非存活者中,IL-6仍保持高水平,IL-8和IL-10进一步升高。所有患者在整个病程中肿瘤坏死因子-α水平均低于检测限。所有存活者血清脂多糖结合蛋白(LBP)在急性期普遍升高,恢复期下降,但1例非存活者在终末期LBP显著升高。急性期,血浆内毒素水平与白细胞计数、中性粒细胞计数及血清IL-8呈正相关。IL-8与中性粒细胞计数呈正相关,与血清胆碱酯酶、肝促凝血酶原激酶试验及血清白蛋白水平呈负相关。IL-6与白细胞和中性粒细胞计数、C反应蛋白、血清总胆红素呈正相关,与肝促凝血酶原激酶试验及血清总蛋白水平呈负相关。血清LBP与白细胞和中性粒细胞计数呈正相关。
内毒素血症及相关的IL-8升高可能在酒精性肝炎患者中性粒细胞的激活和迁移中起重要作用。炎性细胞因子IL-6和IL-8的显著升高与酒精性肝炎的严重程度和不良预后相关。血清LBP可作为酗酒者炎症反应的指标。